RBC Capital Upgrades ISTA Pharmaceuticals (ISTA) to Outperform
Tweet
Share
E-mailGet Alerts ISTA Hot Sheet
Price: $7.02 +1.45%
Rating Summary:
0 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
0 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
RBC Capital upgraded ISTA Pharmaceuticals (NASDAQ: ISTA) from Sector Perform to Outperform.
For more ratings news on ISTA Pharmaceuticals click here and for the rating history of ISTA Pharmaceuticals click here.
Shares of ISTA Pharmaceuticals closed at $10.04 yesterday.
For more ratings news on ISTA Pharmaceuticals click here and for the rating history of ISTA Pharmaceuticals click here.
Shares of ISTA Pharmaceuticals closed at $10.04 yesterday.
Create E-mail Alert Related Categories
UpgradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
